|
Nipple Aspirate Fluid
|
D055966 |
[Fluid collected from nipple by gentle aspiration. The fluid contains cells and extracellular fluid from the breast ductal epithelium.
] |
|
Contact Tracing
|
D016358 |
[Identification of those persons (or animals) who have had such an association with an infected person, animal, or contaminated environment as to have had the opportunity to acquire the infection.
, The first identified case or patient in a communicable disease outbreak.
] |
|
1,2-Dipalmitoylphosphatidylcholine
|
D10.570.755.375.760.400.800.224 |
|
|
Cystinosis
|
C16.320.565.595.377 |
|
|
Physiatrists
|
N02.360.810.764 |
|
|
Gene Products, rex
|
D016370 |
[Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The rex (regulator x; x is undefined) products act by binding to elements in the LONG TERMINAL REPEAT.
] |
|
Bacteriorhodopsins
|
D12.776.752.812.249 |
|
|
DNA, Antisense
|
D016373 |
[DNA that is complementary to the sense strand. (The sense strand has the same sequence as the mRNA transcript. The antisense strand is the template for mRNA synthesis.) Synthetic antisense DNAs are used to hybridize to complementary sequences in target RNAs or DNAs to effect the functioning of specific genes for investigative or therapeutic purposes.
] |
|
Oncogene Proteins v-abl
|
D016374 |
[Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids.
] |
|
Cranial Irradiation
|
D016371 |
[The exposure of the head to roentgen rays or other forms of radioactivity for therapeutic or preventive purposes.
] |
|
RNA, Antisense
|
D016372 |
[RNA molecules which hybridize to complementary sequences in either RNA or DNA altering the function of the latter. Endogenous antisense RNAs function as regulators of gene expression by a variety of mechanisms. Synthetic antisense RNAs are used to effect the functioning of specific genes for investigative or therapeutic purposes.
] |
|
Dietary Sucrose
|
D27.720.372.300.353.609.750.250 |
|
|
Nutritive Sweeteners
|
D27.720.372.300.353.609.750 |
|
|
Resting Phase, Cell Cycle
|
G04.144.500.300 |
|
|
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide
|
D02.092.146.290 |
|
|
Azabicyclo Compounds
|
D02.145.074 |
|
|
Aza Compounds
|
D02.145 |
|
|
Cryptogenic Organizing Pneumonia
|
C08.381.483.487.249 |
|
|
Idiopathic Interstitial Pneumonias
|
C08.381.483.487 |
|
|
Usher Syndromes
|
C10.597.751.418.341.186.500.500 |
|
